U.S. Pharmaceutical Policy in a Global Marketplace
Investigates the effects on consumers of lowering U.S. pharmaceutical prices under various assumptions and finds that publicly financing price reductions, without affecting manufacturer prices, delivers benefits in virtually all plausible cases.